FL S0866

Amends s. 893.0551, F.S. to restrict disclosure of prescription drug monitoring program information to only that which is relevant to an active investigation that prompted the request.

Requires the Attorney General, health care regulatory boards, and law enforcement agencies to redact or delete all nonrelevant confidential information before disclosing data to criminal justice agencies.

Mandates law enforcement agencies enter into a user agreement with the department before receiving prescription drug monitoring database information.

Authorizes health care practitioners to share patient information with the patient and place it in the patient's medical record upon written consent.

Allows the department to provide patient advisory reports to health care practitioners when a pattern of controlled substance abuse is identified, and removes the automatic disclosure requirement to law enforcement agencies.

Permits impaired practitioner consultants retained under s. 456.076 to access controlled substance prescription history information.

Prohibits unauthorized disclosure of confidential information except as specifically authorized, with violations constituting a third-degree felony.

Becomes effective July 1, 2014, and removes the sunset review repeal date of October 2, 2014.